Related references
Note: Only part of the references are listed.Suppression of serum HCV RNA levels during maintenance peginterferon (PEGIFN) alfa-2a therapy and clinical outcomes in the HALT-C trial
M. L. Shiffman et al.
JOURNAL OF HEPATOLOGY (2008)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:: A randomized controlled trial
Vito Di Marco et al.
JOURNAL OF HEPATOLOGY (2007)
Liver biopsy in cirrhotic patients
Kenneth E. Sherman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis
Zachary D. Goodman et al.
HEPATOLOGY (2007)
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
Savino Bruno et al.
HEPATOLOGY (2007)
Evolution of the HALT-C trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders
WM Lee et al.
CONTROLLED CLINICAL TRIALS (2004)
Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa et al.
HEPATOLOGY (2003)
Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study
F Imazeki et al.
HEPATOLOGY (2003)
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease
G Colloredo et al.
JOURNAL OF HEPATOLOGY (2003)
An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C
MJ O'Brien et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
